GeneDx Holdings Corp
WGS
ISIN null / Valor 126808031
GeneDx Holdings Corp
UMushroom community rating:
About company
GeneDx Holdings Corp. (Nasdaq: WGS) is a company specializing in genomic insights to enhance health outcomes. The firm focuses on providing advanced genetic testing and diagnostic services, leveraging cutting-edge technology to offer precise and actionable genomic data. GeneDx's offerings are designed to support healthcare providers in diagnosing and managing a wide range of genetic disorders, thereby improving patient care and treatment strategies. The company is publicly traded and regularly reports its financial performance, with its latest results for the first quarter of 2024 scheduled for release after market close on April 29, 2024.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
2504 M
Market cap (USD)
711,682
Daily traded volume (Shares)
77.8 / 73.985
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
